| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |